サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1434341

栄養補助食品成分市場：形態、健康効果、タイプ、用途別-2023-2030年の世界予測

Nutraceutical Ingredients Market by Form (Dry, Liquid), Health Benefits (Bone Health, Cognitive Performance, Gut Health), Type, Application - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
栄養補助食品成分市場：形態、健康効果、タイプ、用途別-2023-2030年の世界予測
出版日: 2024年01月05日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

栄養補助食品成分市場規模は2022年に1,933億米ドルと推定され、2023年には2,097億9,000万米ドルに達すると予測され、CAGR 8.75%で2030年には3,782億1,000万米ドルに達すると予測されます。

世界の栄養補助食品成分市場

主な市場の統計
基準年[2022］ 1,933億米ドル
予測年[2023] 2,097億9,000万米ドル
予測年 [2030] 3,782億1,000万米ドル
CAGR（%） 8.75%
栄養補助食品成分 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは栄養補助食品成分市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、栄養補助食品成分市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-栄養補助食品成分市場の市場規模および予測は？

2-栄養補助食品成分市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-栄養補助食品成分市場における技術動向と規制の枠組みは？

4-栄養補助食品成分市場における主要ベンダーの市場シェアは？

5-栄養補助食品成分市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 消費者の平均寿命と健康意識の向上
      • 慢性疾患患者の健康のための栄養補助食品の必要性
      • スポーツ栄養および化粧品における多様な用途
    • 抑制要因
      • 栄養補助食品に対する意識の低さと、強化された高成分製品の価格の上昇
    • 機会
      • 製品の進歩と革新の出現
      • 健康的な食生活を促進する政府の取り組み
    • 課題
      • 栄養補助食品成分の研究開発コストが高い
      • 国ごとに異なる規制基準
  • 市場セグメンテーション分析
  • 市場動向分析
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 栄養補助食品成分市場：形態別

  • ドライ
  • 液体

第7章 栄養補助食品成分市場健康給付別

  • 骨の健康
  • 認知パフォーマンス
    • 睡眠促進
    • ストレスマネジメント
  • 腸の健康
  • 心臓の健康
  • 免疫
  • 栄養
  • 体重管理

第8章 栄養補助食品成分市場：タイプ別

  • カロテノイド
  • 繊維と特殊炭水化物
  • ミネラル
  • オメガ3脂肪酸
  • ファイトケミカルと植物エキス
  • プレバイオティクス
  • プロバイオティクス
  • タンパク質とアミノ酸
  • ビタミン

第9章 栄養補助食品成分市場：用途別

  • 動物の栄養学
  • 栄養補助食品
  • 機能性飲料
  • 機能性食品
  • パーソナルケア

第10章 南北アメリカの栄養補助食品成分市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の栄養補助食品成分市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの栄養補助食品成分市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Ajinomoto Co., Inc.
    • Amway Corporation
    • Archer-Daniels-Midland Company
    • Arla Foods amba
    • Associated British Foods PLC
    • Balchem Corporation
    • Barentz International B.V.
    • BASF SE
    • BIONAP S.R.L.
    • Cargill, Incorporated
    • Chr. Hansen Holding A/S
    • ChromaDex, Inc.
    • Danone S.A.
    • Divi's Laboratories Limited
    • DuPont de Nemours, Inc.
    • Fonterra Co-operative Group Limited
    • Glanbia PLC
    • Ingredion Incorporated
    • Kappa Bioscience Europe GmbH
    • Kerry Group PLC
    • Koninklijke DSM N.V.
    • Kyowa Kirin Co., Ltd.
    • Lonza Group
    • Martin Bauer Group
    • Nestle S.A.
    • Pfizer Inc.
    • Sydler India Pvt. Ltd.
    • Tate & Lyle PLC
    • ZIVO Bioscience, Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NUTRACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. NUTRACEUTICAL INGREDIENTS MARKET DYNAMICS
  • FIGURE 7. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2022 VS 2030 (%)
  • FIGURE 8. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2022 VS 2030 (%)
  • FIGURE 10. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 12. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 14. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. NUTRACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. NUTRACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NUTRACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NUTRACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 6. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 9. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY BONE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 12. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY SLEEP BOOSTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STRESS MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY GUT HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEART HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY IMMUNITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY CAROTENOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FIBERS & SPECIALTY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PHYTOCHEMICAL & PLANT EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PROTEINS & AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY COGNITIVE PERFORMANCE, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM NUTRACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NUTRACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 245. NUTRACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 246. NUTRACEUTICAL INGREDIENTS MARKET LICENSE & PRICING
目次
Product Code: MRR-430D3EB72AF6

[184 Pages Report] The Nutraceutical Ingredients Market size was estimated at USD 193.30 billion in 2022 and expected to reach USD 209.79 billion in 2023, at a CAGR 8.75% to reach USD 378.21 billion by 2030.

Global Nutraceutical Ingredients Market

KEY MARKET STATISTICS
Base Year [2022] USD 193.30 billion
Estimated Year [2023] USD 209.79 billion
Forecast Year [2030] USD 378.21 billion
CAGR (%) 8.75%
Nutraceutical Ingredients Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nutraceutical Ingredients Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nutraceutical Ingredients Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nutraceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amway Corporation, Archer-Daniels-Midland Company, Arla Foods amba, Associated British Foods PLC, Balchem Corporation, Barentz International B.V., BASF SE, BIONAP S.R.L., Cargill, Incorporated, Chr. Hansen Holding A/S, ChromaDex, Inc., Danone S.A., Divi's Laboratories Limited, DuPont de Nemours, Inc., Fonterra Co-operative Group Limited, Glanbia PLC, Ingredion Incorporated, Kappa Bioscience Europe GmbH, Kerry Group PLC, Koninklijke DSM N.V., Kyowa Kirin Co., Ltd., Lonza Group, Martin Bauer Group, Nestle S.A., Pfizer Inc., Sydler India Pvt. Ltd., Tate & Lyle PLC, and ZIVO Bioscience, Inc..

Market Segmentation & Coverage

This research report categorizes the Nutraceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Form
    • Dry
    • Liquid
  • Health Benefits
    • Bone Health
    • Cognitive Performance
      • Sleep Boosting
      • Stress Management
    • Gut Health
    • Heart Health
    • Immunity
    • Nutrition
    • Weight Management
  • Type
    • Carotenoids
    • Fibers & Specialty Carbohydrates
    • Minerals
    • Omega-3 Fatty Acids
    • Phytochemical & Plant Extracts
    • Prebiotics
    • Probiotics
    • Proteins & Amino Acids
    • Vitamins
  • Application
    • Animal Nutrition
    • Dietary Supplements
    • Functional Beverages
    • Functional Foods
    • Personal Care
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nutraceutical Ingredients Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nutraceutical Ingredients Market?

3. What are the technology trends and regulatory frameworks in the Nutraceutical Ingredients Market?

4. What is the market share of the leading vendors in the Nutraceutical Ingredients Market?

5. Which modes and strategic moves are suitable for entering the Nutraceutical Ingredients Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Nutraceutical Ingredients Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Life Expectancy and Health Consciousness Among Consumers
      • 5.1.1.2. Need of Nutraceutical Products for Wellbeing of Chronic Disease Patients
      • 5.1.1.3. Diverse Applications in Sports Nutrition and Cosmeceutical
    • 5.1.2. Restraints
      • 5.1.2.1. Low Awareness about Nutraceuticals and Higher Cost of Fortified and Rich-ingredient Products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of Advancements and Innovation in the Products
      • 5.1.3.2. Government Initiative to Promote Healthy Diets
    • 5.1.4. Challenges
      • 5.1.4.1. High R&D Cost of Nutraceutical Ingredients
      • 5.1.4.2. Varying Regulatory Standards Across Different Countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework
  • 5.10. Client Customization

6. Nutraceutical Ingredients Market, by Form

  • 6.1. Introduction
  • 6.2. Dry
  • 6.3. Liquid

7. Nutraceutical Ingredients Market, by Health Benefits

  • 7.1. Introduction
  • 7.2. Bone Health
  • 7.3. Cognitive Performance
    • 7.4.1. Sleep Boosting
    • 7.4.2. Stress Management
  • 7.4. Gut Health
  • 7.5. Heart Health
  • 7.6. Immunity
  • 7.7. Nutrition
  • 7.8. Weight Management

8. Nutraceutical Ingredients Market, by Type

  • 8.1. Introduction
  • 8.2. Carotenoids
  • 8.3. Fibers & Specialty Carbohydrates
  • 8.4. Minerals
  • 8.5. Omega-3 Fatty Acids
  • 8.6. Phytochemical & Plant Extracts
  • 8.7. Prebiotics
  • 8.8. Probiotics
  • 8.9. Proteins & Amino Acids
  • 8.10. Vitamins

9. Nutraceutical Ingredients Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Nutrition
  • 9.3. Dietary Supplements
  • 9.4. Functional Beverages
  • 9.5. Functional Foods
  • 9.6. Personal Care

10. Americas Nutraceutical Ingredients Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nutraceutical Ingredients Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nutraceutical Ingredients Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Ajinomoto Co., Inc.
    • 14.1.2. Amway Corporation
    • 14.1.3. Archer-Daniels-Midland Company
    • 14.1.4. Arla Foods amba
    • 14.1.5. Associated British Foods PLC
    • 14.1.6. Balchem Corporation
    • 14.1.7. Barentz International B.V.
    • 14.1.8. BASF SE
    • 14.1.9. BIONAP S.R.L.
    • 14.1.10. Cargill, Incorporated
    • 14.1.11. Chr. Hansen Holding A/S
    • 14.1.12. ChromaDex, Inc.
    • 14.1.13. Danone S.A.
    • 14.1.14. Divi's Laboratories Limited
    • 14.1.15. DuPont de Nemours, Inc.
    • 14.1.16. Fonterra Co-operative Group Limited
    • 14.1.17. Glanbia PLC
    • 14.1.18. Ingredion Incorporated
    • 14.1.19. Kappa Bioscience Europe GmbH
    • 14.1.20. Kerry Group PLC
    • 14.1.21. Koninklijke DSM N.V.
    • 14.1.22. Kyowa Kirin Co., Ltd.
    • 14.1.23. Lonza Group
    • 14.1.24. Martin Bauer Group
    • 14.1.25. Nestle S.A.
    • 14.1.26. Pfizer Inc.
    • 14.1.27. Sydler India Pvt. Ltd.
    • 14.1.28. Tate & Lyle PLC
    • 14.1.29. ZIVO Bioscience, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing